Anxiety is one of the most common mental health challenges faced by people worldwide. With increasing awareness about mental ...

226 60.6 Social anxiety disorder 124 33.2 Agoraphobia 129 34.6 Panic disorder 131 35.1 Comorbid major depression 265 71.0 Was hospitalized for at least one night for mental health reasons 42 11.3 ...

This study examined the relationship between postpartum hair loss and psychological symptoms.This questionnaire-based, cross-sectional study included postpartum women who had delivered at two ...

Miindfulness-based stress reduction may be as effective as escitalopram (Lexapro — an SSRI commonly used to treat depression ...

A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a cancerous chemical.

The Boston-based biotech will use the new fundraise to develop its pipeline of drug candidates for conditions such as major ...

Global Cannabis Use Disorder Treatment Market. The global cannabis use disorder treatment market is expected to grow from USD ...

After launching her mental health wellness site, Wondermind, she opened up about her “debilitating” anxiety and how she used ...

AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric ...

A prescription digital therapeutic for insomnia was associated with significant improvements in sleep, depression, and anxiety.

AbbVie (ABBV) and Gedeon Richter announced a new discovery, co-development and license agreement to advance novel targets for the potential ...